Evidence map›Paper›PMID 32163139›Full record

Trial reportCardiovascular research2021

Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction: a substudy of the CONDI-2/ERIC-PPCI randomized controlled trial.

Diana A Gorog, Mohamed Farag, Nikolaos Spinthakis, Derek M Yellon, Hans Erik Bøtker, Rajesh K Kharbanda, Derek J Hausenloy

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 5 countries.

Diana A GorogNational Heart and Lung Institute, Faculty of Medicine, Imperial College, Dovehouse Street, London SW3 6LR, UK.
Mohamed FaragPostgraduate Medical School, University of Hertfordshire, Hertfordshire, UK.
Nikolaos SpinthakisPostgraduate Medical School, University of Hertfordshire, Hertfordshire, UK.
Derek M YellonThe Hatter Cardiovascular Institute, University College London, London, UK.
Hans Erik BøtkerDepartment of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
Rajesh K KharbandaCardiology Department, Oxford Heart Centre, Oxford University Hospitals NHS Trust, Oxford, UK.
Derek J HausenloyThe Hatter Cardiovascular Institute,  University College London, London, UK.
University of Hertfordshire · GBAarhus University Hospital · DKAsia University · TWUniversity College London · GBUniversity of Oxford · GB

Funding

British Heart Foundation CS/14/3/31002British Heart Foundation FS/10/039/28270Medical Research Council MC_G1002673
6 · The paper itself

Abstract

aimsRemote ischaemic conditioning (RIC) has been shown to reduce myocardial infarct size in animal models of myocardial infarction. Platelet thrombus formation is a critical determinant of outcome in ST-segment elevation myocardial infarction (STEMI). Whether the beneficial effects of RIC are related to thrombotic parameters is unclear. METHODS AND

resultsIn a substudy of the Effect of Remote Ischaemic Conditioning on clinical outcomes in STEMI patients undergoing Primary Percutaneous Coronary Intervention (ERIC-PPCI) trial, we assessed the effect of RIC on thrombotic status. Patients presenting with STEMI were randomized to immediate RIC consisting of an automated autoRIC™ cuff on the upper arm inflated to 200 mmHg for 5 min and deflated for 5 min for four cycles (n = 53) or sham (n = 47). Venous blood was tested at presentation, discharge (48 h) and 6-8 weeks, to assess platelet reactivity, coagulation, and endogenous fibrinolysis using the Global Thrombosis Test and thromboelastography. Baseline thrombotic status was similar in the two groups. At discharge, there was some evidence that the time to in vitro thrombotic occlusion under high shear stress was longer with RIC compared to sham (454 ± 105 s vs. 403 ± 105 s; mean difference 50.1 s; 95% confidence interval 93.7-6.4, P = 0.025), but this was no longer apparent at 6-8 weeks. There was no difference in clot formation or endogenous fibrinolysis between the study arms at any time point.

conclusionRIC may reduce platelet reactivity in the first 48 h post-STEMI. Further research is needed to delineate mechanisms through which RIC may reduce platelet reactivity, and whether it may improve outcomes in patients with persistent high on-treatment platelet reactivity.

Indexed as

FibrinolysisIschemic PreconditioningPercutaneous Coronary InterventionPlatelet ActivationAgedArmBlood PlateletsDual Anti-Platelet TherapyFemaleHumansMaleMiddle AgedRegional Blood FlowSingle-Blind MethodST Elevation Myocardial InfarctionThrombosisIschaemic conditioningPlatelet reactivityPPCISTEMIThrombosis

Identifiers

PMID32163139
PMCPMC7820881
OpenAlexW3011795061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.